top of page
Intellectual Property Services
The defining characteristic of the international research-based pharmaceutical industry is its commitment to innovative, but expensive, R&D investment, and the cornerstone of protecting this investment is via executing a robust intellectual property (IP) policy.
At TBS we understand the importance of IP policy and how it relates to ensuring that an asset is protected, compliant and fulfills its maximum Return on Investment (RoI). Whether you are an innovator seeking protection for a New Chemical Entity (NCE) or a generic/biosimilar manufacturer, we can help create a clear road map to launch your products.
Let's Work Together
bottom of page